PATHOGENETIC MECHANISMS OF MIGRAINE DEVELOPMENT ASSOCIATED WITH HOMOCYSTEINE

FULL TEXT:

Abstract

The article studies various mechanisms of the influence of homocysteine ​​in the development of migraine. Homocysteine, a sulfur-containing molecule, is now recognized as an independent risk factor for various thrombotic diseases, especially coronary heart disease and stroke. This article is aimed at providing various mechanisms of development and association of migraine with homocysteine, which will allow in choosing the right treatment tactics.

About the Authors

List of references

Cacciapuoti F. Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors. Blood Coag. Fibrinol. 2012; 23: 677– 9.

Tommaso MD, Losito L, Livrea P. The role of homocysteine in the pathogenesis and development of migraine. Cephalalgia 2005; 25: 823– 1020.

Lea A, Menon S, Colson NJ et al. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res. Notes 2010; 3: 213.

Gavgani SC, Hoseinian MM. Comparative study on homocysteine levels in migraine patients and normal peoples. Ann. Biol. Res. 2012; 3(4): 1804– 7.

Hosseini M, Houshmad M, Ebraini A. MTHFR polymorphism and breast cancer risk. Arch. Med. Sci. 2011; 7: 134– 7.

Antoniades C, Shirodaria C, Leeson P et al. MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, no homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009; 119: 2507– 15.

Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetatrahydrofolate reductase gene is generic risk factor for migraine. Am. J. Med. Genet. 2000; 96: 762– 4.

Lorenz AL, Kahre T, Mihailov E et al. Are methylenetetrahydrofolate reductase (MTHFR) gene polymorphism C677T and A1298 C associated with higher risk of pediatric migraine in boys and girls? J. Biom. Sci. Eng. 2014; 7: 464– 72.

Liu R, Geng P, Ma M et al. MTHFR C677T ploymorfism and migraine risk: a meta-analysis. J. Neurol. Sci. 2014; 336: 68– 73.

Moskowitz MA. The neurobiology of vascular head pain. Ann. Neurol. 1984; 16: 157– 68.

Lea R, Colson N, Quinlan S, McMillan J, Griffiths L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet. Genomics 2009; 19: 422– 8.

Shaik MM, Gan SH. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. BioMed. Res. Intern. 2015. https://doi.org/10.1155/2015/469529

Tchantchou F, Graves M, Falcone D, Shea TB. S-adenosyl-methionine mediates glutathione efficacy by increasing glutathione-S-transferase activity: implications for the S-adenosylmethionine as a protective dietary activity supplement. J. Alzheimer Dis. 2008; 14: 323– 8.

Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochem. (Moscow) 2009; 74: 589– 98.

Cararo JH, Streck EL, Schuck PF, Ferreira C. Carnosine and related peptides: potential in age-related disorders. Aging. Dis. 2015; 5: 369– 79.

Views: 59